{
    "nctId": "NCT03246841",
    "briefTitle": "Investigation of Tumour Spectrum of Germline Mutations in Breast and Ovarian Cancer Genes.",
    "officialTitle": "Investigation of Tumour Spectrum, Penetrance and Clinical Utility of Germline Mutations in New Breast and Ovarian Cancer Susceptibility Genes.",
    "overallStatus": "ACTIVE_NOT_RECRUITING",
    "conditions": "Hereditary Breast and Ovarian Cancer, Mutation",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "PREVENTION",
    "enrollmentCount": 7274,
    "primaryOutcomeMeasure": "Penetrance estimation of the mutations identified in the gene panel",
    "eligibilityCriteria": "Inclusion criteria:\n\nIndex case eligibility:\n\nAny person with an indication for a BRCA1/BRCA2 gene analysis and who has been offered TUMOSPEC panel screening.\n\nAge \u226518 years.\n\nFamily member eligibility:\n\nFamily members will be eligible if the mutation identified in the Index Case is considered deleterious.\n\nAny family member to the first and second decree or a cousin of the Index Case. Family members from both sides of the family will be invited to take part.\n\nAge \u226518 years.\n\nExclusion Criteria:\n\nPeople deprived of their civil liberties or who are under judicial protection or guardianship.\n\nPatients unable to answer the questionnaire for social or psychological reasons.\n\nChildren of the index cases, of any age.",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}